(Q33988072)

English

Treatment of chronic hepatitis B virus infection in special groups of patients: decompensated cirrhosis, immunosuppressed and paediatric patients

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

Treatment of chronic hepatitis B virus infection in special groups of patients: decompensated cirrhosis, immunosuppressed and paediatric patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

immunosuppression

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

Merican I

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

1 May 2000

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Journal of Gastroenterology and Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

15 Suppl

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

E71-8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

The development of cirrhosis in patients with chronic type B hepatitis: A prospective study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Natural history and prognostic factors for chronic hepatitis type B

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Mechanisms of action of interferons

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Survival and prognostic indicators in compensated and decompensated cirrhosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Interferon alfa-2b for decompensated liver disease caused by either chronic hepatitis B or C: preliminary results of a pilot study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Low-dose, titratable interferon alfa in decompensated liver disease caused by chronic infection with hepatitis B virus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Prolonged interferon-alpha therapy of hepatitis B virus-related decompensated cirrhosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Expression of epithelial-cadherin, alpha-catenin and beta-catenin during human intrahepatic bile duct development: a possible role in bile duct morphogenesis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Potential role of lamivudine (3TC) in the clearance of chronic hepatitis B virus infection in a patient coinfected with human immunodeficiency virus type

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Recombinant alpha interferon for chronic hepatitis B in anti-HIV positive patients receiving zidovudine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Tolerance and latent cellular rejection in long-term liver transplant recipients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Liver cirrhosis associated with chronic hepatitis B virus infection in childhood

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Primary hepatocellular carcinoma and hepatitis B infection during childhood

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

A longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive chinese children

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Interferon alfa-2b therapy in children with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Interferon-alpha therapy for chronic hepatitis B in children: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Safety and efficacy of interferon retreatment in children with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Cost-benefit analysis of interferon therapy in children with chronic active hepatitis B.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Incidence of cirrhosis in children with chronic hepatitis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

PLACEBO-CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE HBsAg-CARRIER CHILDREN

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Interferon alfa treatment of chronic hepatitis B: Randomized trial in a predominantly homosexual male population

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02104.X

21 January 2018

Identifiers

10.1046/J.1440-1746.2000.02104.X

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33988072&oldid=1980709161"